Mar 2, 2021
In this episode, Angela Rasmussen, PhD, discusses her path to becoming a virologist, her insights on risk mitigation strategies, and what’s next in her career.
- Intro :13
- About Rasmussen :16
- The interview 1:06
- Can you tell us a little bit about how you became a virologist? 1:18
- Did you ever imagine that you would be in the eye of the storm, so to speak, in a public health crisis like the one we’re facing now? 2:53
- Can you kind of walk us through, from when this whole pandemic started, to now, how has your role evolved? 4:43
- So, were you surprised, as all of this was happening, when this pandemic became such a polarizing subject? 9:23
- What do you think is needed today in order for us to actually fix our response? 14:36
- What is it going to take to get that faith in the medical and scientific communities and public health messaging when there was already so much hesitancy to begin with? 18:24
- When do you think we’re going to stop wearing masks, realistically, in this country? 24:45
- The importance of funding for preventive health infrastructures 31:26
- Were you, by any chance, on Jeopardy!? What was that experience like? 35:49
- You mentioned you’re making a big move, an international move … where are you going and what are you going be doing in the next part of your career? 39:57
- Rasmussen’s one pearl of wisdom 43:33
- Where to find Rasmussen 44:09
Angela Rasmussen, PhD, is a virologist currently affiliated with the Georgetown Center for Global Health Science and Security. In spring 2021, Rasmussen will be starting a lab at the Vaccine and Infectious Disease Organization-International Vaccine Centre, a vaccine research institute at the University of Saskatchewan. She is a member of the Verena Consortium, a multi-disciplinary, international effort to predict and study emerging viral pathogens.
We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Dr. Rasmussen can be reached on Twitter @angie_rasmussen and via her website, angelarasmussen.org. Follow us on Twitter @HemOncToday @ShikhaJainMD.
Disclosures: Jain reports she is a paid freelance writer for Lippincott. Rasmussen reports no relevant financial disclosures.